Transcranial sonography findings related to non-motor features of Parkinson's disease

Journal of the Neurological Sciences

Volumn 289, Issue 1-2, 2010, Pages 123-127

  Walter, Uwe ^a   Školoudík, David ^b,c   Berg, Daniela ^d  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^c PALACKÝ UNIVERSITY   (Czech Republic)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Caudate nucleus; Dementia; Depression; Parkinson's disease; Psychosis; Raphe nuclei; Transcranial sonography; Urinary urge incontinence

Indexed keywords

ARTICLE; CAUDATE NUCLEUS; DEMENTIA; DEPRESSION; DOPPLER ECHOGRAPHY; DRUG INDUCED DISEASE; HIGH RISK POPULATION; HUMAN; MESENCEPHALON; NEUROIMAGING; PARKINSON DISEASE; PATHOGENICITY; PRIORITY JOURNAL; PSYCHOSIS; URINE INCONTINENCE;

EID: 74149083311     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.08.027     Document Type: Article

References (55)

1. Becker G., Perez J., Krone A., Demuth K., Lindner A., Hofmann E., et al. Transcranial color-coded real-time sonography in the evaluation of intracranial neoplasms and arteriovenous malformations. Neurosurgery 31 (1992) 420-428
2. Becker G., Krone A., Koulis D., Lindner A., Hofmann E., Roggendorf W., et al. Reliability of transcranial colour-coded real-time sonography in assessment of brain tumours: correlation of ultrasound, computed tomography and biopsy findings. Neuroradiology 36 (1994) 585-590
3. Seidel G., Kaps M., and Dorndorf W. Transcranial color-coded duplex sonography of intracerebral hematomas in adults. Stroke 24 (1993) 1519-1527
4. Berg D., Godau J., and Walter U. Transcranial sonography in movement disorders. Lancet Neurol 7 (2008) 1044-1055
5. Walter U., Kanowski M., Kaufmann J., Grossmann A., Benecke R., and Niehaus L. Contemporary ultrasound systems allow high-resolution transcranial imaging of small echogenic deep intracranial structures similarly as MRI: a phantom study. Neuroimage 40 (2008) 551-558
6. Walter U., Behnke S., Eyding J., Niehaus L., Postert T., Seidel G., et al. Transcranial brain parenchyma sonography in movement disorders: state of the art. Ultrasound Med Biol 33 (2007) 15-25
7. Huang Y.W., Jeng J.S., Tsai C.F., Chen L.L., and Wu R.M. Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease. Mov Disord 22 (2007) 550-555
8. Kim J.Y., Kim S.T., Jeon S.H., and Lee W.Y. Midbrain transcranial sonography in Korean patients with Parkinson's disease. Mov Disord 22 (2007) 1922-1926
9. Skoloudík D., Fadrná T., Bártová P., Langová K., Ressner P., Zapletalová O., et al. Reproducibility of sonographic measurement of the substantia nigra. Ultrasound Med Biol 33 (2007) 1347-1352
10. Becker G., Seufert J., Bogdahn U., Reichmann H., and Reiners K. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 45 (1995) 182-184
11. Becker T., Becker G., Seufert J., Hofmann E., Lange K.W., Naumann M., et al. Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry 63 (1997) 590-596
12. Berg D., Supprian T., Hofmann E., Zeiler B., Jäger A., Lange K.W., et al. Depression in Parkinson's disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging. J Neurol 246 (1999) 1186-1193
13. Berg D., Siefker C., and Becker G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 248 (2001) 684-689
14. Walter U., Niehaus L., Probst T., Benecke R., Meyer B.U., and Dressler D. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 60 (2003) 74-77
15. Walter U., Dressler D., Wolters A., Wittstock M., and Benecke R. Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease. Mov Disord 22 (2007) 48-54
16. Berg D., Becker G., Zeiler B., Tucha O., Hofmann E., Preier M., et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 53 (1999) 1026-1031
17. Walter U., Wittstock M., Benecke R., and Dressler D. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J Neural Transm 109 (2002) 191-196
18. Stockner H., Sojer M., K.K.S., Mueller J., Wenning G.K., Schmidauer C., et al. Midbrain sonography in patients with essential tremor. Mov Disord 22 (2007) 414-417
19. Ressner P., Skoloudík D., Hlustík P., and Kanovský P. Hyperechogenicity of the substantia nigra in Parkinson's disease. J Neuroimaging 17 (2007) 164-167
20. Okawa M., Miwa H., Kajimoto Y., Hama K., Morita S., Nakanishi I., et al. Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations. Intern Med 46 (2007) 1527-1531
21. Doepp F., Plotkin M., Siegel L., Kivi A., Gruber D., Lobsien E., et al. Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor. Mov Disord 23 (2008) 405-410
22. Berg D., Merz B., Reiners K., Naumann M., and Becker G. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov Disord 20 (2005) 383-385
23. Berg D., Hochstrasser H., Schweitzer K.J., and Riess O. Disturbance of iron metabolism in Parkinson's disease - ultrasonography as a biomarker. Neurotox Res 9 (2006) 1-13
24. Walter U., Hoeppner J., Prudente-Morrissey L., Horowski S., Herpertz S.C., and Benecke R. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain 130 (2007) 1799-1807
25. Behnke S., Berg D., Naumann M., and Becker G. Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry 76 (2005) 423-425
26. Walter U., Dressler D., Probst T., Wolters A., Abu-Mugheisib M., Wittstock M., et al. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease. Arch Neurol 64 (2007) 1635-1640
27. Reijnders J.S., Ehrt U., Weber W.E., Aarsland D., and Leentjens A.F. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 23 (2008) 183-189
28. Becker G., Struck M., Bogdahn U., and Becker T. Echogenicity of the brainstem raphe in patients with major depression. Psychiatry Res 55 (1994) 75-84
29. Becker G., Becker T., Struck M., Lindner A., Burzer K., Retz W., et al. Reduced echogenicity of brainstem raphe specific to unipolar depression: a transcranial color-coded real-time sonography study. Biol Psychiatry 38 (1995) 180-184
30. Walter U., Prudente-Morrissey L., Herpertz S.C., Benecke R., and Hoeppner J. Relationship of brainstem raphe echogenicity and clinical findings in depressive states. Psychiatry Res 155 (2007) 67-73
31. Walter U., Krolikowski K., Tarnacka B., Benecke R., Czlonkowska A., and Dressler D. Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease. Neurology 64 (2005) 1726-1732
32. Berg D., Supprian T., Thomae J., Warmuth-Metz M., Horowski A., Zeiler B., et al. Lesion pattern in patients with multiple sclerosis and depression. Mult Scler 6 (2000) 156-162
33. Becker G., Berg D., Lesch K.P., and Becker T. Basal limbic system alteration in major depression: a hypothesis supported by transcranial sonography and MRI findings. Int J Neuropsychopharmacol 4 (2001) 21-31
34. Supprian T., Reiche W., Schmitz B., Grunwald I., Backens M., Hofmann E., et al. MRI of the brainstem in patients with major depression, bipolar affective disorder and normal controls. Psychiatry Res 131 (2004) 269-276
35. Reimold M., Batra A., Knobel A., Smolka M.N., Zimmer A., Mann K., et al. Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study. Mol Psychiatry 13 (2008) 606-613
36. Gaenslen A., Unmuth B., Godau J., Liepelt I., Di Santo A., Schweitzer K.J., et al. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Lancet Neurol 7 (2008) 417-424
37. Berg D., Siefker C., Ruprecht-Dörfler P., and Becker G. Relationship of substantia nigra echogenicity and motor function in elderly subjects. Neurology 56 (2001) 13-17
38. Berg D., Jabs B., Merschdorf U., Beckmann H., and Becker G. Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. Biol Psychiatry 50 (2001) 463-467
39. Berg D., Roggendorf W., Schröder U., Klein R., Tatschner T., Benz P., et al. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 59 (2002) 999-1005
40. Sommer U., Hummel T., Cormann K., Mueller A., Frasnelli J., Kropp J., et al. Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT. Mov Disord 19 (2004) 1196-1202
41. Walter U., Klein C., Hilker R., Benecke R., Pramstaller P.P., and Dressler D. Brain parenchyma sonography detects preclinical parkinsonism. Mov Disord 19 (2004) 1445-1449
42. Hoeppner J., Prudente-Morrissey L., Herpertz S.C., Benecke R., and Walter U. Substantia nigra hyperechogenicity in depressive subjects relates to motor asymmetry and impaired word fluency. Eur Arch Psychiatry Clin Neurosci 259 (2009) 92-97
43. Aarsland D., Zaccai J., and Brayne C. A systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord 20 (2005) 1255-1263
44. Buter T.C., van den Hout A., Matthews F.E., Larsen J.P., Brayne C., and Aarsland D. Dementia and survival in Parkinson disease: a 12-year population study. Neurology 70 (2008) 1017-1022
45. Burton E.J., McKeith I.G., Burn D.J., and O'Brien J.T. Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging. Mov Disord 20 (2005) 1571-1576
46. Walter U., Dressler D., Wolters A., Wittstock M., Greim B., and Benecke R. Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia. J Neurol 253 (2006) 448-454
47. Walter U., Dressler D., Wolters A., Probst T., Grossmann A., and Benecke R. Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy. Neurology 63 (2004) 504-509
48. Ravina B, Marder K, Fernandez HH, Friedman JH, McDonald W, Murphy D, et al. Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov Disord 2007;22:1061-8.
49. Lach B., Grimes D., Benoit B., and Minkiewicz-Janda A. Caudate nucleus pathology in Parkinson's disease: ultrastructural and biochemical findings in biopsy material. Acta Neuropathol (Berl) 83 (1992) 352-360
50. Keshavan M.S., Rosenberg D., Sweeney J.A., and Pettegrew J.W. Decreased caudate volume in neuroleptic-naive psychotic patients. Am J Psychiatry 155 (1998) 774-778
51. Winge K., and Fowler C.J. Bladder dysfunction in Parkinsonism: mechanisms, prevalence, symptoms, and management. Mov Disord 21 (2006) 737-745
52. Walter U., Dressler D., Wolters A., Wittstock M., and Benecke R. Overactive bladder in Parkinson's disease: alteration of brainstem raphe detected by transcranial sonography. Eur J Neurol 13 (2006) 1291-1297
53. De Groat W.C. Influence of central serotonergic mechanisms on lower urinary tract function. Urology 59 Suppl 1 (2002) 30-36
54. Andersson K.E., and Pehrson R. CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention. Drugs 63 (2003) 2595-2611
55. Lee K.S., Na Y.G., Dean-McKinney T., Klausner A.P., Tuttle J.B., and Steers W.D. Alterations in voiding frequency and cystometry in the clomipramine induced model of endogenous depression and reversal with fluoxetine. J Urol 170 (2003) 2067-2071